Artiva Biotherapeutics ($ARTV)

Description

Develops off-the-shelf, non-genetically modified natural killer cell therapies for deep B-cell depletion, aiming to help patients with autoimmune diseases such as rheumatoid arthritis.

Related

• Kyverna Therapeutics (San Diego)Develops cell therapies for autoimmune disease patients, including an autologous CD19-targeting CAR T candidate being studied in ongoing…
• Aspen NeuroscienceDevelops autologous iPSC-derived cell therapies using a patient’s own cells, initially targeting Parkinson’s disease by replacing lost…
• Cartesian Therapeutics ($RNAC)Develops clinical-stage mRNA cell therapies designed to treat autoimmune diseases, aiming to expand access to cell therapy for patients…
• Sana Biotechnology ($SANA)Builds engineered cell medicines that repair or control genes, or replace damaged cells, for patients with diseases including diabetes,…
• Boundless Bio ($BOLD)Develops ecDNA-directed cancer therapies that target vulnerabilities in cancer cells for patients with intractable oncogene-amplified…
• Century TherapeuticsDevelops off-the-shelf cell therapy candidates from induced pluripotent stem cells for patients with autoimmune conditions, including type…
• ONK TherapeuticsONK Therapeutics develops ready-made natural killer cell therapies.
• Cabaletta Bio ($CABA)Develops engineered T cell therapies for autoimmune diseases, including rese-cel in Phase 1/2 trials for lupus, myositis, systemic…
• Intelligent Therapeutics, Inc.Engineers antibodies and antibody-like molecules for treating solid tumors and rare autoimmune diseases, with pipeline work in companion…
• Allterum TherapeuticsDevelops 4A10, an anti-CD127 monoclonal antibody for cancers with CD127 expression, aiming to treat acute lymphoblastic leukemia, B-cell…
• Vor BiopharmaDevelops telitacicept, a BAFF/APRIL inhibitor for autoimmune diseases, aiming to rebalance immunity by blocking survival signals for…
• Umoja BiopharmaDevelops in vivo CAR T cell therapies and lentiviral manufacturing to support on-demand treatment, aiming to reduce ex vivo manufacturing…